Login


Notice: Passwords are now case-sensitive

Remember Me
Register a new account
Forgot your password?

Connections

Groups

Community Requests

The WCC website will be down for scheduled maintenance on Sunday, July 22, from 3:30 PM to 4:30 PM

PEOs, Formulary Updates Are Subjects of Proposed Regulations

Wednesday, July 11, 2018 | 137 | 0 | 21 min read

The Ohio Bureau of Workers’ Compensation has published a notice of rules awaiting a recommendation under the state’s “common sense” initiative: an update to the BWC prescription drug formulary and rules regarding professional employer organizations. The proposed formulary update, which would take effect Jan. 1, would eliminate migraine drug Treximet and generic equivalents from the formulary. Relistor, a drug used to treat opioid-induced constipation, would be eliminated and replaced with Symproic. But BWC has specific requirements for reimbursing Symproic, including ...

Purchase this story for only $9.16!Add to Cart


For access to all of our articles, check out our subscription options.

Comments

Be the first to comment.

Related Articles